Trademark Overview
On Tuesday, July 1, 2025, a trademark application was filed for ACCUMULUS TECHNOLOGIES with the United States Patent and Trademark Office. The USPTO has given the ACCUMULUS TECHNOLOGIES trademark a serial number of 99261835. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Tuesday, July 1, 2025. This trademark is owned by Accumulus Synergy, Inc.. The ACCUMULUS TECHNOLOGIES trademark is filed in the Advertising, Business and Retail Services, Computer & Software Products & Electrical & Scientific Products, Education & Entertainment Services, and Computer & Software Services & Scientific Services categories with the following description:
Arranging and conducting of symposia in the field of modernizing and streamlining regulatory interactions across the life sciences ecosystem; Education services, namely, providing seminars and non-downloadable webinars in the field of modernizing and streamlining regulatory interactions across the life sciences ecosystem
Downloadable electronic publications in the nature of articles in the field of modernizing and streamlining regulatory interactions across the life sciences ecosystem
Promoting the interests of people concerned with modernizing and streamlining regulatory interactions across the life sciences ecosystem issues; Promoting collaboration within the scientific, research and provider communities to achieve advances in the field of modernizing and streamlining regulatory interactions across the life sciences ecosystem; Promoting public awareness of the need for modernizing and streamlining regulatory interactions across the life sciences ecosystem by means of public advocacy
Software as a service (SAAS) services featuring software for aggregating, converting, processing and transferring health, medical and scientific data to a cloud platform enabling the exchange of data between and among life sciences companies, biopharmaceutical companies, medical research and health organizations and global health regulators, and other government agencies for the purpose of expediting regulatory review of pharmaceutical products